Page last updated: 2024-10-28

fasudil and Altitude Hypoxia

fasudil has been researched along with Altitude Hypoxia in 2 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopez, NC1
Ebensperger, G1
Herrera, EA1
Reyes, RV1
Calaf, G1
Cabello, G1
Moraga, FA1
BeƱaldo, FA1
Diaz, M1
Parer, JT1
Llanos, AJ1
Kojonazarov, B1
Myrzaakhmatova, A1
Sooronbaev, T1
Ishizaki, T1
Aldashev, A1

Trials

1 trial available for fasudil and Altitude Hypoxia

ArticleYear
Effects of fasudil in patients with high-altitude pulmonary hypertension.
    The European respiratory journal, 2012, Volume: 39, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acclimatization; Altitude Sickness; Humans; Hypertens

2012

Other Studies

1 other study available for fasudil and Altitude Hypoxia

ArticleYear
Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2016, 06-01, Volume: 310, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Altitude Sickness; Animals; Animals, Newborn; Humans;

2016